Transcarent buys health navigation incumbent Accolade for $621Mnews2025-01-08T17:23:49+00:00January 8th, 2025|Endpoints News|
Compounding pharmacies face an uphill battle in fight over tirzepatidenews2025-01-07T16:26:18+00:00January 7th, 2025|Endpoints News|
Highlander Health acquires Target RWE to improve clinical trialsnews2025-01-07T11:00:39+00:00January 7th, 2025|Endpoints News|
Eli Lilly seeks to join lawsuit over end of tirzepatide shortagenews2025-01-03T18:08:24+00:00January 3rd, 2025|Endpoints News|
Commure’s latest acquisition sends follow-up texts to patientsnews2024-12-20T13:00:23+00:00December 20th, 2024|Endpoints News|
What health tech startups can expect in 2025news2024-12-19T16:48:39+00:00December 19th, 2024|Endpoints News|
In blow to compounders, FDA reaffirms tirzepatide shortage is overnews2024-12-19T15:36:52+00:00December 19th, 2024|Endpoints News|
Health tech industry predicts cautious funding optimism in 2025news2024-12-19T14:30:21+00:00December 19th, 2024|Endpoints News|
Ex-Color Health execs raise $10M to bring AI to pharmanews2024-12-19T12:00:18+00:00December 19th, 2024|Endpoints News|
Major PBM reforms feature in Congress’ year-end spending billnews2024-12-17T20:26:20+00:00December 17th, 2024|Endpoints News|
